Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

Immuneering (IMRX) Return on Assets: 2021-2023

Historic Return on Assets for Immuneering (IMRX) over the last 2 years, with Dec 2023 value amounting to -0.51%.

  • Immuneering's Return on Assets fell 11.00% to -0.51% in Q4 2023 from the same period last year, while for Dec 2023 it was -0.51%, marking a year-over-year decrease of 11.00%. This contributed to the annual value of -0.49% for FY2023, which is 14.00% down from last year.
  • Immuneering's Return on Assets amounted to -0.51% in Q4 2023, which was down 14.66% from -0.44% recorded in Q3 2023.
  • Over the past 5 years, Immuneering's Return on Assets peaked at -0.20% during Q4 2021, and registered a low of -0.51% during Q4 2023.
  • Over the past 3 years, Immuneering's median Return on Assets value was -0.37% (recorded in 2022), while the average stood at -0.36%.
  • Data for Immuneering's Return on Assets shows a maximum YoY dropped of 20bps (in 2023) over the last 5 years.
  • Immuneering's Return on Assets (Quarterly) stood at -0.20% in 2021, then dropped by 19bps to -0.40% in 2022, then fell by 11bps to -0.51% in 2023.
  • Its Return on Assets stands at -0.51% for Q4 2023, versus -0.44% for Q3 2023 and -0.45% for Q2 2023.